Home > Children & Young People > Immunisation >

TB screening and BCG

Checked: 12-11-2023 by Vicky Ryan Next Review: 12-11-2024

TB Screening

TB screening in primary care (Pathway 2) 2020

TB screening for new entrants aged 0 - 16 (Pathway 3) 2018 - for new entrants from countries of high TB incidence

BCG pathway - Bristol and South Glos

The BCG pathway for Bristol and South Glos gives information on how to identify and refer children for BCG immunisation. Please use the referral form which is also available in EMIS.

Please also see the TB Nurse Service page on the Sirona website

BCG - North Somerset

The BCG pathway for Bristol and South Glos also has useful information for North Somerset GP practices.

BCG Hospital Clinics

St Michael’s BCG outpatients clinic (for babies born at St Michael’s / aged under one year) Tel: 0117 3426888 (outpatient call centre) neonatologyadministration@uhbw.nhs.uk
Bristol Children’s Hospital outpatients clinic (for eligible children moving in to the area (1-16) or babies over the age of one who missed the vaccination as an infant) PaedIDImmunology@uhbw.nhs.uk Tel: 0117 3427716
Southmead Hospital (for babies born at Southmead and Cossham) Tel: 0117 4145807 bcgoutpatients@nbt.nhs.uk
Weston infants, Seashore Centre, Weston Hospital Tel: 01934 881123

Bath - babies born at RUH are vaccinated by HCRG Care Group at the RUH. The eligible babies should be referred to the BCG service following the Newborn Infant Physical Examination

Information for families on TB, BCG vaccine and babies can be downloaded: https://www.gov.uk/government/publications/tb-bcg-and-your-baby-leaflet

Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.

Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.